Sophiris bio inc. (SPHS)
Income statement / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12
License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

5,000

-

Operating expenses:
Research and development

738

1,089

1,555

1,991

1,798

3,591

3,330

1,942

1,649

1,387

1,208

1,007

624

978

929

1,669

2,555

2,557

3,081

4,080

6,710

7,088

6,830

4,136

2,117

1,155

2,871

3,411

General and administrative

1,388

1,218

1,252

935

1,155

1,096

1,243

1,311

1,685

1,367

1,369

1,204

3,043

1,357

1,164

660

921

997

1,048

1,016

1,370

1,495

1,451

1,502

883

880

1,246

1,980

Total operating expenses

2,126

2,307

2,807

2,926

2,953

4,687

4,573

3,253

3,334

2,754

2,577

2,211

3,667

2,335

2,093

2,329

3,476

3,554

4,129

5,096

8,080

8,583

8,281

5,638

3,000

2,035

4,117

5,391

Other income (expense):
Interest expense

145

159

167

170

173

172

169

172

35

0

0

0

86

137

150

163

174

177

176

175

175

168

208

244

313

352

399

445

Interest income

29

-

-

-

80

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

-

43

61

-

-

91

87

78

56

53

51

26

3

3

5

4

4

6

8

12

10

12

17

-

-

-

-

-

Gain on revaluation of warrant liability

1,281

270

553

8,546

153

-1,365

1,356

-597

670

3,320

-86

1,639

-350

-1,619

0

-

0

0

-

0

0

20

29

-

-

-

-

-

Loss on early extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-180

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Gain on revaluation of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-195

-

-

-

Other income (expense), net

2

-11

-

-5

21

36

-30

-21

-11

-9

-7

-1

-4

-3

-4

-12

-9

-13

-7

-19

21

-31

-17

-50

166

-255

-101

206

Total other income (expense)

1,167

143

447

8,446

81

-1,410

1,244

-712

680

3,364

-42

1,664

-617

-1,756

-149

-171

-179

-184

-175

-182

-144

-167

-179

200

48

-607

-500

-239

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,438

-2,952

-2,642

383

-5,630

Income tax expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

500

-

Net loss

-959

-2,164

-2,360

5,520

-2,872

-6,097

-3,329

-3,965

-2,654

610

-2,619

-547

-4,284

-4,091

-2,242

-2,500

-3,655

-3,738

-4,304

-5,278

-8,224

-8,750

-8,460

-5,438

-2,952

-2,642

-117

-5,630

Basic income (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-0.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted income (loss) per share (in dollars per share)

-

-

-

-

-

-

-

-

-

0.02

-

-

-

-0.21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of outstanding shares basic (in shares)

-

-

-

-

-

-

-

-

-

30,111

-

-

-

19,340

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of outstanding shares diluted (in shares)

-

-

-

-

-

-

-

-

-

30,515

-

-

-

19,340

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted loss per share (in dollars per share)

-0.03

-0.07

-0.08

0.18

-0.10

-0.20

-0.11

-

-0.09

-

-0.09

-

-0.17

-

-0.13

-0.14

-0.22

-0.22

-0.26

-0.31

-0.49

-0.53

-0.52

-0.20

-0.31

-0.84

-0.04

-1.79

Weighted average number of outstanding shares – basic and diluted (in shares)

32,072

30,217

30,215

30,127

30,111

30,111

30,111

-

30,111

-

30,111

-

25,215

-

17,244

16,989

16,845

16,845

16,845

16,856

16,845

16,493

16,150

16,307

9,509

3,150

3,150

3,150

Other comprehensive loss:
Foreign currency translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-154

191

108

211

Unrealized income on securities available-for-sale

1

1

-2

2

2

2

-3

1

11

-1

-13

-

0

0

0

0

0

-1

1

-2

-1

1

3

-

-

-

-

-

Total other comprehensive loss

-958

-2,163

-2,362

5,522

-2,870

-6,095

-3,332

-3,964

-2,643

609

-2,632

-547

-4,284

-4,091

-2,242

-2,500

-3,655

-3,739

-4,303

-5,280

-8,225

-8,749

-8,457

-5,439

-3,106

-2,451

-9

-5,419